Last reviewed · How we verify
Uriadec (TOPIROXOSTAT)
Uriadec (generic name: TOPIROXOSTAT) is a Small molecule drug developed by Senwa Kegaku Kenkyushp. It is currently FDA-approved for Gout, Hyperuricemia.
Uriadec is a small molecule inhibitor of the enzyme xanthine dehydrogenase/oxidase. It is classified as a xanthine dehydrogenase inhibitor, which suggests its use in treating conditions associated with excessive uric acid production.
At a glance
| Generic name | TOPIROXOSTAT |
|---|---|
| Sponsor | Senwa Kegaku Kenkyushp |
| Target | ATP-binding cassette sub-family G member 2, Xanthine dehydrogenase/oxidase, Xanthine dehydrogenase/oxidase |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Gout
- Hyperuricemia
Common side effects
Key clinical trials
- Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types) (PHASE2)
- Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Uriadec CI brief — competitive landscape report
- Uriadec updates RSS · CI watch RSS
Frequently asked questions about Uriadec
What is Uriadec?
What is Uriadec used for?
Who makes Uriadec?
What is the generic name of Uriadec?
What development phase is Uriadec in?
What does Uriadec target?
Related
- Target: All drugs targeting ATP-binding cassette sub-family G member 2, Xanthine dehydrogenase/oxidase, Xanthine dehydrogenase/oxidase
- Therapeutic area: All drugs in Other
- Indication: Drugs for Gout
- Indication: Drugs for Hyperuricemia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing